Kezar Life Sciences GAAP EPS of -$1.53 beats by $0.42
Source: SeekingAlpha
2025-11-13 00:53:51 ET
More on Kezar Life Sciences
- Seeking Alpha’s Quant Rating on Kezar Life Sciences
- Historical earnings data for Kezar Life Sciences
- Financial information for Kezar Life Sciences
Read the full article on Seeking Alpha
For further details see:
Kezar Life Sciences GAAP EPS of -$1.53 beats by $0.42
Kezar Life Sciences Inc.
NASDAQ: KZR
KZR Trading
-0.7% G/L:
$7.08 Last:
6,050 Volume:
$7.25 Open:
KZR Latest News
March 12, 2026 09:00:00 am
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
January 09, 2026 06:01:00 am
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
KZR Stock Data
$44,671,252
5,118,886
0.48%
17
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
